Mallinckrodt PLC shares tumbles after the drug company says it has filed suit against the U.S. Department of Health and Human Services and Centers for Medicare and Medicaid Services to protect Medicaid patient access to its Acthar gel.
MarketWatch.com - Top Stories, MarketWatch
Tue, 05/21/2019 - 10:15am